Year in review 2010: Critical Care - multiple organ dysfunction and sepsis

Critical Care

Volumn 15, Issue 6, 2011, Pages

  de Montmollin, Etienne ^a   Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; BRAIN DYSFUNCTION; HUMAN; INFLAMMATION; INTENSIVE CARE; METABOLIC DISORDER; MICROVASCULARIZATION; MULTIPLE ORGAN FAILURE; MYOCARDIAL DISEASE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS; REVIEW; SEPSIS; VENTILATOR INDUCED LUNG INJURY; PATHOPHYSIOLOGY;

HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 82755186505     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10359     Document Type: Review

References (38)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042.
2. Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J, . Grupo de Estudios y Análisis en Cuidados Intensivos Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158. 2646323, 19091069, Grupo de Estudios y Análisis en Cuidados Intensivos.
3. Vincent JL, Nelson DR, Williams MD. Is worsening multiple organ failure the cause of death in patients with severe sepsis?. Crit Care Med 2011, 39:1050-1055. 10.1097/CCM.0b013e31820eda29, 21317650.
4. Chierego M, Verdant C, De Backer D. Microcirculatory alterations in critically ill patients. Minerva Anestesiol 2006, 72:199-205.
5. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
6. Shapiro N, Schuetz P, Yano K, Sorasaki M, Parikh S, Jones A, Trzeciak S, Ngo L, Aird W. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010, 14:R182. 10.1186/cc9290, 3219288, 20942957.
7. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008, 29:452-457. 10.1097/SHK.0b013e31815072c1, 18598002.
8. Lund DD, Brooks RM, Faraci FM, Heistad DD. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol 2007, 293:H3726-3731. 10.1152/ajpheart.01116.2007, 17965276.
9. Doerschug K, Delsing A, Schmidt G, Ashare A. Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 2010, 14:R24. 10.1186/cc8887, 2875539, 20175923.
10. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009, 31:348-353. 10.1097/SHK.0b013e318188bd06, 18791490.
11. Davis J, Yeo T, Piera K, Woodberry T, Celermajer D, Stephens D, Anstey N. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 2010, 14:R89. 10.1186/cc9020, 2911723, 20482750.
12. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002, 95:89-100. 10.1016/S0163-7258(02)00236-X, 12163130.
13. Landsberger M, Zhou J, Wilk S, Thaumüller C, Pavlovic D, Otto M, Whynot S, Hung O, Murphy MF, Cerny V, Felix SB, Lehmann C. Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats. Crit Care 2010, 14:R223. 10.1186/cc9367, 3220004, 21143965.
14. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, . VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265, VASST Investigators.
15. Rehberg S, Ertmer C, Lange M, Morelli A, Whorton E, Dünser M, Strohhäcker AK, Lipke E, Kampmeier TG, Van Aken H, Traber DL, Westphal M. Role of selective V(2)-receptor-antagonism in septic shock: a randomized, controlled, experimental study. Crit Care 2010, 14:R200. 10.1186/cc9320, 3220000, 21054850.
16. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, . Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873. 10.1097/01.CCM.0000117317.18092.E4, 15090974, Surviving Sepsis Campaign Management Guidelines Committee.
17. Cardoso T, Carneiro AH, Ribeiro O, Teixeira-Pinto A, Costa-Pereira A. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 2010, 14:R83. 10.1186/cc9008, 2911711, 20459716.
18. Mousavi N, Czarnecki A, Ahmadie R, Tielan F, Kumar K, Lytwyn M, Kumar A, Jassal DS. The utility of tissue Doppler imaging for the noninvasive determination of left ventricular filling pressures in patients with septic shock. J Intensive Care Med 2010, 25:163-167. 10.1177/0885066609359903, 20444737.
19. Sturgess D, Marwick T, Joyce C, Jenkins C, Jones M, Masci P, Stewart D, Venkatesh B. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 2010, 14:R44. 10.1186/cc8931, 2887156, 20331902.
20. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169. 10.1056/NEJMra032401, 15247356.
21. Nejat M, Pickering J, Walker R, Westhuyzen J, Shaw G, Frampton C, Endre Z. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 2010, 14:R85. 10.1186/cc9014, 2911717, 20459852.
22. Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008, 36:1297-1303. 10.1097/CCM.0b013e318169245a, 2757115, 18379258.
23. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walter R, Kielstein J. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010, 14:R9. 10.1186/cc8861, 2875521, 20122150.
24. Schortgen F, Girou E, Deye N, Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 34:2157-2168. 10.1007/s00134-008-1225-2, 18685828.
25. Wiedermann C, Dunzendorfer S, Gaioni L, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010, 14:R191. 10.1186/cc9308, 3219298, 21029460.
26. Martínez-Caro L, Lorente JA, Marín-Corral J, Sánchez-Rodríguez C, Sánchez-Ferrer A, Nin N, Ferruelo A, de Paula M, Fernández-Segoviano P, Barreiro E, Esteban A. Role of free radicals in vascular dysfunction induced by high tidal volume ventilation. Intensive Care Med 2009, 35:1110-1119. 10.1007/s00134-009-1469-5, 19360397.
27. Vaschetto R, Kuiper J, Musters R, Eringa E, Della Corte F, Murthy K, Groeneveld AJ, Plötz F. Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway. Crit Care 2010, 14:R45. 10.1186/cc8932, 2887157, 20346119.
28. Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van der Voort E, de Groot R. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996, 173:1148-1156. 10.1093/infdis/173.5.1148, 8627066.
29. Madách K, Aladzsity I, Szilágyi T, Fust G, Gál J, Pénzes I, Prohászka Z. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care 2010, 14:R79. 10.1186/cc8992, 2887202, 20429897.
30. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, . Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group.
31. Maybauer MO, Maybauer DM, Fraser JF, Szabo C, Westphal M, Kiss L, Horvath EM, Nakano Y, Herndon DN, Traber LD, Traber DL. Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock. Crit Care 2010, 14:R217. 10.1186/cc9342, 3220026, 21110850.
32. Marti-Carvajal AJ, Sola I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 2011, 4:CD004388.
33. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
34. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
35. Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care 2008, 12:R49. 10.1186/cc6868, 2447603, 18412978.
36. Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, Lin J, Hewett D, Moorhead KT, Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit Care 2010, 14:R154. 10.1186/cc9224, 2945138, 20704712.
37. Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: inflammation in man and mouse. Neurochem Int 2011, 58:472-476. 10.1016/j.neuint.2011.01.004, 21219956.
38. Taccone FS, Su F, Pierrakos C, He X, James S, Dewitte O, Vincent J-L, De Backer D. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit Care 2010, 14:R140. 10.1186/cc9205, 2945121, 20667108.